Dr Rebecca Bilardi
Honorary (Fellow)
Department of Medical Biology (WEHI)
15 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Mbd4 and MutSα protect cells from spontaneous deamination of 5-methylcytosine
DOI: 10.1093/nar/gkaf14932023
Journal article
Uridine-cytidine kinase 2 potentiates the mutagenic influence of the antiviral β-d-N4-hydroxycytidine
DOI: 10.1093/nar/gkad10022022
Journal article
Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignancies
DOI: 10.1186/s13073-022-01131-w2020
Journal article
HBO1 is required for the maintenance of leukaemia stem cells
DOI: 10.1038/s41586-019-1835-62019
Journal article
Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice
DOI: 10.1038/s41418-018-0209-12016
Journal article
MOZ (KAT6A) is essential for the maintenance of classically defined adult hematopoietic stem cells
DOI: 10.1182/blood-2015-10-6760722016
Journal article
Impact of loss of BH3-only proteins on the development and treatment of MLL-fusion gene-driven AML in mice
DOI: 10.1038/cddis.2016.258
RECENT SCHOLARLY WORKS
2013
Journal article
HoxA9 regulated Bcl-2 expression mediates survival of myeloid progenitors and the severity of HoxA9-dependent leukemia
DOI: 10.18632/oncotarget.13062012
Journal article
Processing of anthracycline-DNA adducts via DNA replication and interstrand crosslink repair pathways
DOI: 10.1016/j.bcp.2012.01.0292011
Journal article
M2, a novel anthracenedione, elicits a potent DNA damage response that can be subverted through checkpoint kinase inhibition to generate mitotic catastrophe
DOI: 10.1016/j.bcp.2011.08.013